---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-052898"
form_type: "8-K"
ticker: "GRML"
cik: "0001907223"
company_name: "Greenland Mines Ltd"
filed_at: "2025-06-10T23:59:59+00:00"
generated_at: "2026-05-19T16:11:45.564654+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Klotho Neurosciences announces s-KL longevity study; also closes $500K stock sale and reprices warrants

## Summary
- Pre-clinical study shows s-KL protein increased lifespan 20% in mice; company holds exclusive license for s-KL patents from UAB/ICREA.
- Sold 4M shares for $500K ($0.125/share) in unregistered sale on June 5, 2025.
- Repriced 4,515,762 public warrants to $1.35/share on June 10, 2025; other terms unchanged.
- CEO focuses s-KL development on neurodegenerative diseases: ALS, Alzheimer's, Parkinson's.
- Prof. Makoto Kuro-O, original Klotho discoverer, serves as scientific advisor.

## SEC filing metadata
- accession: 0001213900-25-052898
- form_type: 8-K
- ticker: GRML
- cik: 0001907223
- company_name: Greenland Mines Ltd
- filed_at: 2025-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907223/000121390025052898/0001213900-25-052898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907223/000121390025052898/ea0245180-8k_klotho.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-052898
- JSON: https://secwatch.observer/filing/0001213900-25-052898.json
- Plain text: https://secwatch.observer/filing/0001213900-25-052898.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.